Posted Jan. 9, 2014 at 10:40 a.m.

Premium Lock GSK wins 'accelerated approval' for combination cancer treatment targeting melanoma

Published: 2014-01-09 10:40:51
Updated: 2014-01-09 10:40:51

Cancer research Cancer research

In what GlaxoSmithKline says is a first, the drug giant has received FDA approval for a combination of its cancer drugs that target a form of melanoma linked to specific genetic mutations....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll